Clinical Trials Sponsored by Zafgen, Inc.
Total 37185 results
-
AmgenTerminatedSystemic Lupus ErythematosusUnited States, Spain, Serbia, Mexico, Poland, Greece, Argentina, India, Taiwan
-
AmgenCompletedChronic Myelomonocytic Leukemia | Higher Risk Myelodysplastic SyndromeUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
AmgenWithdrawn
-
AmgenCompletedMigraine HeadacheUnited States, Austria, Australia, Czechia, Finland, France, Hungary, Italy, Poland, Portugal, Spain, United Kingdom
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
AmgenCompletedSystemic Lupus Erythematosus (SLE)United States, Korea, Republic of, Australia, Spain, Hungary, Bulgaria, Italy, Mexico, Germany, Japan, France, Greece, Czechia, Argentina, Portugal, Poland, Russian Federation, Hong Kong, Canada
-
AmgenCompletedAdvanced Non CNS TumorsUnited States, Belgium, Spain, France, Canada, Italy, Switzerland
-
AmgenCompletedPlaque PsoriasisUnited States, Poland, Canada, Germany, Estonia, Latvia
-
AmgenTerminatedGastric and Gastroesophageal Junction AdenocarcinomaKorea, Republic of, Taiwan, Spain, Austria, United States, France, Japan, Germany, Netherlands
-
AmgenCompleted
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
AmgenCompletedPsoriasisUnited States, Poland, Canada, Germany, Estonia, Georgia, Hungary, Latvia
-
AmgenCompleted
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
AmgenCompletedArthritis, PsoriaticNetherlands
-
AmgenWithdrawn
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompleted
-
AmgenCompletedHepatic ImpairmentUnited States
-
AmgenCompletedElectrocardiographyUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsVasculitis | Systemic Lupus Erythematosus (SLE)Switzerland
-
AmgenCompletedSystemic Lupus ErythematosusUnited States, Poland, Germany, France
-
AmgenCompletedGastric or Gastroesophageal CancerJapan
-
AmgenCompletedDyslipidemia | Medical Conditions to be Studied | ASCVD ManagementUnited States
-
AmgenTerminatedMixed Dyslipidemia | Primary HypercholesterolemiaChina
-
AmgenCompletedPsoriatic ArthritisSpain, Belgium, Denmark, United States, Germany, Russian Federation, Austria, United Kingdom, Canada, Italy, Switzerland
-
AmgenCompletedHealthy VolunteersUnited States
-
AmgenCompletedRheumatoid ArthritisUnited States, Germany, Italy, Mexico, France, Canada, Hungary, Portugal, Spain, Greece, Bulgaria, Czechia, Poland, Argentina, South Africa
-
AmgenCompletedMultiple MyelomaBelgium, Austria, Czechia, Greece, Italy, France, Romania, Netherlands, Israel, Bulgaria, Norway
-
AmgenCompletedMetastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon CancerUnited States, Belgium, Canada, Italy, Germany, Spain
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
AmgenCompletedOsteoporosis, Age-RelatedUnited States, Canada
-
AmgenCompletedPostmenopausal OsteoporosisCanada, Belgium, United States, Czechia, Denmark, Poland, Hungary, Spain, Colombia, United Kingdom, Argentina
-
AmgenTerminatedAnemia | Chronic Kidney Disease | Kidney DiseaseUnited States, Belgium, Mexico, United Kingdom, Puerto Rico, Poland, Russian Federation, Latvia, Lithuania, Slovakia
-
AmgenCompletedGCT | Giant Cell Tumor of Bone
-
AmgenCompleted
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Taiwan, Korea, Republic of, Australia, Belgium, Canada, South Africa, France, Turkey
-
AmgenTerminatedMelanoma | Cancer | Colorectal Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Oncology | Tumors | Advanced Malignancy | Oncology Patients | Transitional Cell Carinoma of BladderBelgium, France, United States, Germany, Australia
-
AmgenCompletedHeterozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Norway, Belgium, Turkey, Australia, New Zealand, Austria, Czechia, South Africa, Poland, Spain, Switzerland, Netherlands, Taiwan, Finland, Brazil, Portugal, Slovenia, Russian Federation, Hungary, United... and more
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompleted
-
AmgenCompletedMigraineUnited States, Denmark, France, Spain, Portugal, Russian Federation, Greece, Switzerland